Filippo de Braud

1. Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
   2018/11/07 by Vincenzo Mazzaferro, Bassel F. El‐Rayes, Bassel F. El-Rayes +19 · 29 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Cholangiocarcinoma and Gallbladder Cancer Studies #Fibroblast Growth Factor Research #Gastrointestinal Tumor Research and Treatment
2. Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
   2011/05/01 by H Joensuu, Heikki Joensuu, Filippo de Braud +26 · 15 citations
   Medicine · #Gastrointestinal Tumor Research and Treatment #Gastrointestinal Bleeding Diagnosis and Treatment #Gastrointestinal disorders and treatments